Nvidia announced the launch of Cambridge-1, the most powerful supercomputer in the UK
Nvidia announced the official launch of the UK’s most powerful supercomputer Cambridge-1, as an industry with an investment of $100 million, committed to promoting the development of the medical industry. Researchers and scientists can use artificial intelligence to accelerate the biological revolution.
Nvidia has already cooperated with AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and Oxford Nanopore. The first projects include an in-depth understanding of brain diseases such as dementia, using artificial intelligence to assist in the development of new drugs, and improving the accuracy of research on finding pathogenic variants in the human genome.
Image: Nvidia
Cambridge-1 brings together NVIDIA’s decades of work in accelerated computing, artificial intelligence, and life sciences. It optimizes NVIDIA Clara and its artificial intelligence framework to use the entire system for large-scale research and is powered by 100% renewable energy.
As the NVIDIA DGX SuperPOD supercomputing cluster, Cambridge-1 ranks among the top 50 supercomputers in the world. NVIDIA plans to cooperate with researchers to provide most of the computing work to the scientific community. It has 80 DGX A100 systems, integrated NVIDIA A100 GPU, BlueField -2 DPU, and NVIDIA HDR InfiniBand network. It is an NVIDIA DGX SuperPOD that can provide more than 400 petaflops of AI performance and 8 petaflops of Linpack performance.
The supercomputer system is placed in a facility operated by NVIDIA partner Kao Data. It is NVIDIA’s first supercomputer dedicated to the promotion of specific industry research in the UK. Nvidia also plans to establish an AI center in Cambridge to build a new supercomputer based on the ARM architecture to support the development needs of more industries in the UK.
